Corticosteroids in Patients Hospitalized With Community-Acquired Pneumonia: Systematic Review and Individual Patient Data MetaanalysisMatthias Briel, Simone M.C. Spoorenberg, Dominic Snijders et al.|Clinical Infectious Diseases|2017Cited by 154
Pharmacokinetics of oral <i>vs</i>. intravenous dexamethasone in patients hospitalized with community‐acquired pneumoniaSimone M.C. Spoorenberg, E.M.W. van de Garde, Ger T. Rijkers et al.|British Journal of Clinical Pharmacology|2013Cited by 95
Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysisSimone M.C. Spoorenberg, E.M.W. van de Garde, Willem Jan W. Bos et al.|BMC Infectious Diseases|2014Cited by 58
Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trialEsther Wittermans, Stefan M.T. Vestjens, Simone M.C. Spoorenberg et al.|European Respiratory Journal|2021Cited by 56
High‐sensitivity cardiac troponin <scp>T</scp> predicts mortality after hospitalization for community‐acquired pneumoniaStefan M.T. Vestjens, Simone M.C. Spoorenberg, Ger T. Rijkers et al.|Respirology|2017Cited by 51